Last updated on February 2018

BGB 3111 in Combination With Obinutuzumab in Subjects With B-Cell Lymphoid Malignancies

Brief description of study

This study is evaluating the safety and preliminary efficacy of BGB-3111 in combination with obinutuzumab in subjects with B-cell lymphoid malignancies.

Clinical Study Identifier: NCT02569476

Contact Investigators or Research Sites near you

Start Over

William Novonty, MD

The Alfred Hospital
Melbourne, Australia
  Connect »

William Novonty, MD

St Frances Xavier Cabrini Hospital
Malvern, Australia
  Connect »

William Novonty, MD

St Vincent's Hospital Melbourne
East Melbourne, Australia
  Connect »